DAPA VILDA 50/5 combines two potent medications, Dapagliflozin (5mg) and Vildagliptin SR (50mg), to manage type 2 diabetes mellitus. This combination helps in improving blood sugar control and reducing the risk of complications associated with diabetes.

How Does It Work?

Dapagliflozin: This medication works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys. By doing so, it prevents glucose reabsorption and promotes glucose excretion through urine, thus lowering blood sugar levels.

Vildagliptin: It works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4). This increases the levels of incretin hormones, which in turn stimulate insulin release and reduce glucagon levels, resulting in better blood sugar control.

Uses of DAPA VILDA 50/5

• Blood Sugar Control: Helps in regulating high blood sugar levels in adults with type 2 diabetes.
• Complementary Therapy: Can be used alongside diet and exercise or with other medications to achieve optimal glycemic control.
• Reducing Complications: Aims to lower the risk of diabetes-related complications such as cardiovascular diseases.

What is DAPA VILDA 50/5?

DAPA VILDA 50/5 is a combination oral tablet containing 5mg of Dapagliflozin and 50mg of Vildagliptin in a sustained-release formulation. It is prescribed for the management of type 2 diabetes to improve glycemic control.

Side Effects

• Common Side Effects:

  • Urinary tract infections
  • Nasopharyngitis
  • Headache
  • Dizziness

• Serious Side Effects:

  • Severe hypoglycemia
  • Pancreatitis
  • Kidney problems
  • Allergic reactions

Safety Information

• Hydration: Ensure adequate fluid intake to prevent dehydration due to increased urination.
• Kidney Function: Regular monitoring of kidney function is recommended.
• Liver Function: Monitor liver enzymes regularly.
• Allergies: Avoid use if allergic to Dapagliflozin, Vildagliptin, or any of the excipients.
• Pregnancy and Breastfeeding: Consult your healthcare provider before use.

If You Need More Information About  DAPA VILDA 50/5  Click here